Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schlichting

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|September 1, 1985
Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significanceE Christensen, P Schlichting, L Fauerholdt, et al.
Abdominal Imaging|March 1, 1997
Magnetic resonance imaging of Crohn disease: early recognition of treatment response and relapseS M Madsen, H S Thomsen, P Munkholm, et al.
Ugeskrift for Laeger|September 1, 1980
[Extended Danish classification of liver- and bile duct diseases (the DASL-code)]P Schlichting, H Baden, E Juhl, et al.
Gastroenterology|November 1, 1981
Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisoneE Christensen, L Fauerholdt, P Schlichting, et al.
Abdominal Imaging|May 5, 1999
Evaluation of treatment response in active Crohn's disease by low-field magnetic resonance imagingS M Madsen, H S Thomsen, P Schlichting, et al.
Scandinavian Journal of Gastroenterology|December 29, 1998
Active Crohn's disease and ulcerative colitis evaluated by low-field magnetic resonance imagingS M Madsen, H S Thomsen, P Munkholm, et al.
Liver|March 1, 1981
Clinical relevance of restrictive morphological criteria for the diagnosis of cirrhosis in liver biopsiesP Schlichting, L Fauerholdt, E Christensen, et al.
Liver|June 1, 1982
Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic markerP Schlichting, L Fauerholdt, E Christensen, et al.
Liver|June 1, 1982
Prednisone and chronic liver disease. II. Clinical versus morphological criteria for selection of patients for prednisone treatmentP Schlichting, E Christensen, L Fauerholdt, et al.
Journal of Internal Medicine|January 13, 2001
Ethical aspects of clinical trials: the attitudes of participants in two non-cancer trialsS M Madsen, S Holm, B Davidsen, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|September 1, 1985
Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significanceE Christensen, P Schlichting, L Fauerholdt, et al.
Abdominal Imaging|March 1, 1997
Magnetic resonance imaging of Crohn disease: early recognition of treatment response and relapseS M Madsen, H S Thomsen, P Munkholm, et al.
Ugeskrift for Laeger|September 1, 1980
[Extended Danish classification of liver- and bile duct diseases (the DASL-code)]P Schlichting, H Baden, E Juhl, et al.
Gastroenterology|November 1, 1981
Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisoneE Christensen, L Fauerholdt, P Schlichting, et al.
Abdominal Imaging|May 5, 1999
Evaluation of treatment response in active Crohn's disease by low-field magnetic resonance imagingS M Madsen, H S Thomsen, P Schlichting, et al.
Scandinavian Journal of Gastroenterology|December 29, 1998
Active Crohn's disease and ulcerative colitis evaluated by low-field magnetic resonance imagingS M Madsen, H S Thomsen, P Munkholm, et al.
Liver|March 1, 1981
Clinical relevance of restrictive morphological criteria for the diagnosis of cirrhosis in liver biopsiesP Schlichting, L Fauerholdt, E Christensen, et al.
Liver|June 1, 1982
Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic markerP Schlichting, L Fauerholdt, E Christensen, et al.
Liver|June 1, 1982
Prednisone and chronic liver disease. II. Clinical versus morphological criteria for selection of patients for prednisone treatmentP Schlichting, E Christensen, L Fauerholdt, et al.
Journal of Internal Medicine|January 13, 2001
Ethical aspects of clinical trials: the attitudes of participants in two non-cancer trialsS M Madsen, S Holm, B Davidsen, et al.
Pageof 7